Moreover, activated PSCs-secreted galectin-1 promotes the apoptosis of CD3+CD4+ and CD3+CD8+ effector T cells, developing a PSC-dependent immunoprivilege in the pancreatic cancer microenvironment (53). This evidence concerns the gene CD8A and pancreatic neoplasm.